{"text": "the protocol is eligible to be exempt .The NIH OBA has proposed .exemption criteria that are objective to facilitate uniform decisions .across IBCs .", "label": "", "metadata": {}, "score": "42.638824"}
{"text": "new , pertinent information that needs to be assimilated into future protocol approvals .Continuing review is conducted by the convened board unless the specific report does not affect subject safety or falls within the minimal risk categories defined under Expedited review .", "label": "", "metadata": {}, "score": "43.123333"}
{"text": "( b ) any modifications to the protocol as required by FDA ; ( 6 ) .applicable NIH grant number(s ) ; ( 7 ) the FDA Investigational New Drug .", "label": "", "metadata": {}, "score": "43.26159"}
{"text": "The consent form approved by the MCW / FH IRB will typically be used .The consent form should be provided to the other sites .", "label": "", "metadata": {}, "score": "43.495552"}
{"text": "This study was approved through expedited review by the University of Texas Health Science Center at San Antonio ( UTHSCSA ) Institutional Review Board ( IRB ) with verbal consent .", "label": "", "metadata": {}, "score": "44.013626"}
{"text": "If modifications to the protocol or consent form were required , standard operating procedures at the Coordinating Center stipulate that changes be implemented for the individual site only and not implemented at the other sites .", "label": "", "metadata": {}, "score": "44.409225"}
{"text": "Who can submit studies ?MCW / FH Other Committees that may need to review a new study .Some new protocols may require review by various administrative or ancillary committees prior to being reviewed by the IRB .", "label": "", "metadata": {}, "score": "45.368427"}
{"text": "The following factors are reviewed as the study progresses : . the accruing of safety and effectiveness data that may warrant revision to the protocol . changes in key contact personnel . changes in research regulations .", "label": "", "metadata": {}, "score": "45.497658"}
{"text": "How the investigator(s ) .responded to each of the RAC 's recommendations on the protocol ( if . applicable ) , and ( b ) any modifications to the protocol as required . by FDA ; ( 6 ) applicable NIH grant number(s ) ; ( 7 ) the FDA .", "label": "", "metadata": {}, "score": "45.579338"}
{"text": "This timeframe ensures the changes can be implemented in a timely process to protect the rights , safety and welfare of their subjects and the continued conduct of the project in accordance with the protocol .", "label": "", "metadata": {}, "score": "46.51333"}
{"text": "Institutional Biosafety Committee ( IBC ) and/or IRB ; ( 3 ) a copy of .the final IBC approval from the clinical trial site , if required ; .", "label": "", "metadata": {}, "score": "46.904922"}
{"text": "If the reviewers determine changes must be made to your research proposal , you will be contacted directly and the following is required : .Provide a written response to each of the stipulations in a cover letter detailing any changes made to the protocol and supporting documents .", "label": "", "metadata": {}, "score": "46.969448"}
{"text": "Two of the hospitals ( hospital H and hospital N ) had to adjust their start - up time based on competing demands and arising priorities ( e.g. , local credentialing visits by Joint Commission and various other organizations ) .", "label": "", "metadata": {}, "score": "47.180862"}
{"text": "Institutional Biosafety Committee ( IBC ) and IRB ; ( 3 ) a copy of the . final IBC approval from the clinical trial site ; ( 4 ) a copy of the . final IRB approval ; ( 5 ) a brief written report that includes the . following information : ( a )", "label": "", "metadata": {}, "score": "48.87285"}
{"text": "Approval for your modification request must be granted by the IRB before the changes to your protocol can be implemented .Training Requirements .Please see the table below for training requirements and instructions for various learner groups .", "label": "", "metadata": {}, "score": "49.968067"}
{"text": "Results .Type of Review .Each of the 14 sites received IRB approval from their IRB of record without revisions to the protocol , consent form , or resubmissions .", "label": "", "metadata": {}, "score": "50.713287"}
{"text": "For example , an institution may designate the Biological Safety .Officer and the IBC Chair to review data from the initial trial and . determine whether a subsequent trial using the same agent meets the .", "label": "", "metadata": {}, "score": "51.19718"}
{"text": "This will facilitate questions such as what the MCW / FH / BCW investigator needs to provide to the reviewing IRB , what consent form should be used , where to find the IRB approval letter , etc . .", "label": "", "metadata": {}, "score": "51.530807"}
{"text": "The IRB must review every HSS research protocol ( the detailed document prepared by researchers outlining how the study will be conducted ) that involves human subjects .", "label": "", "metadata": {}, "score": "51.674473"}
{"text": "The consent must be written in language that is clear and easily understood .It is important that the research candidate have time to read and understand the consent form , and to have all questions answered by an investigator or qualified hospital staff .", "label": "", "metadata": {}, "score": "51.81424"}
{"text": "A retrospective cohort comparison design was approved by the institutional review board at the regional hospital and used to gather data from the infants ' medical records during the study period .", "label": "", "metadata": {}, "score": "52.203022"}
{"text": "during the review of the documentation submitted in support of the . initial clinical trial and the clinical experience from the initial . trial .Again , IBCs have the institutional prerogative to require .", "label": "", "metadata": {}, "score": "52.5971"}
{"text": "It is important to understand that the IRB has final authority within the institution with regards to clinical research involving human participants .Research Regulations and Guidelines .", "label": "", "metadata": {}, "score": "52.73002"}
{"text": "If the consenting was to be done individually , as time permitted , then research staff would be the ones consenting study participants .This was explicitly written into the protocol implementation kit as well as discussed in detail during the protocol training / study initiation meeting .", "label": "", "metadata": {}, "score": "53.03488"}
{"text": "The IRB must re - evaluate approved research at intervals appropriate to the degree of risk .At initial review , the IRB determines the length of this approval period , not to exceed one year .", "label": "", "metadata": {}, "score": "53.12788"}
{"text": "At time of initial approval , the IRB provides the principal investigator with study specific guidance as to what safety information shall be reported , when , and to whom .", "label": "", "metadata": {}, "score": "53.213127"}
{"text": "Samples provided through this protocol will be used solely for in vitro research .Samples will be assigned a unique product number , and the study investigators listed on this protocol will serve as the custodians of the code that links the product with a donor s identity .", "label": "", "metadata": {}, "score": "53.48857"}
{"text": "[ Time Frame : Throughout study , as normal controls are needed .][ Designated as safety issue : No ] .This protocol is designed to provide blood , skin , buccal mucosa and bone marrow aspirate samples from approximately 250 healthy volunteer donors for use in in vitro studies of mast cells , mastocytosis , and allergic diseases .", "label": "", "metadata": {}, "score": "53.549736"}
{"text": "The investigational nature of the studies in which samples will be used , as well as the risks and benefits of the donation process , will be explained to all donors , and a signed informed consent document will be obtained .", "label": "", "metadata": {}, "score": "53.73964"}
{"text": "This study aimed to improve culture within the hospital and implement evidence - based practice to prevent CLABSI .This study was reviewed by the John Hopkins IRB and was considered exempted from further review .", "label": "", "metadata": {}, "score": "54.010246"}
{"text": "Additionally , the structure and process of documenting operational failures and system context were done so in an anonymous fashion , ensuring confidentiality for the protection of participants against risk and harm .", "label": "", "metadata": {}, "score": "54.300804"}
{"text": "Two of the sites that underwent expedited review had concerns about the database security .Standard procedures and accessibility guidelines were provided to these IRBs by the ISRN Coordinating Center and the study was ultimately approved .", "label": "", "metadata": {}, "score": "54.45125"}
{"text": "Institutional policies at MCW / FH / BCW continue to apply , including OCRICC review and approval , Safety Committee review and approval , human subjects protection training , and conflict of interest .", "label": "", "metadata": {}, "score": "54.46696"}
{"text": "A paper is published from another study that shows that the risks or potential benefits of the research might be different from those initially presented to the IRB .", "label": "", "metadata": {}, "score": "54.7198"}
{"text": "An ad hoc review of IRB application materials and correspondences was conducted .Where materials were unclear , the coordinating center contacted the site PI and/or local IRB for clarification .", "label": "", "metadata": {}, "score": "54.75924"}
{"text": "These documents were sent along with the PIK to each site principal investigator for use in preparation of local IRB submissions .Each site was also requested to ask their local IRB to sign an investigator agreement to allow the UTHSCSA IRB and its Federalwide Assurance ( FWA ) to have oversight of the research site to speed up the implementation of the STAR-2 study .", "label": "", "metadata": {}, "score": "54.882122"}
{"text": "However , once submitted , these two hospitals received IRB approval and started the study within one standard deviation of the average approval time .Eliminating these two sites as outliers , average time to submission was 33 days .", "label": "", "metadata": {}, "score": "55.171173"}
{"text": "While IBCs . will no longer be required to review all clinical trials using the same .product , each institution can implement its own policies regarding the .", "label": "", "metadata": {}, "score": "55.418877"}
{"text": "Studies involving no greater than minimal risk AND fitting one of nine specific categories ( per applicable regulations ) may be reviewed administratively by a single designated IRB member or a small review panel , as determined by institutional procedures .", "label": "", "metadata": {}, "score": "55.502457"}
{"text": "The consent language agreed to , and the process for obtaining consent , must be carefully documented .Research subject privacy and confidentiality must be adequately protected .", "label": "", "metadata": {}, "score": "55.510265"}
{"text": "Continued dialogue between improvement researchers and review board chairs is needed for this to happen .By working with a national organization such as the ISRN and the resources it provides , variations in IRB approvals can be limited as evident by the results of this study .", "label": "", "metadata": {}, "score": "55.74192"}
{"text": "The PIK included standardized materials to implement this project uniformly across each site .The UTHSCSA IRB approved this study prior to sending materials to each site .", "label": "", "metadata": {}, "score": "56.113102"}
{"text": "When a trial is only conducted at a single .site , the burden of a single IBC review should not be significant or .unduly delay the research .", "label": "", "metadata": {}, "score": "56.282425"}
{"text": "review of the initial trial .In addition , members of the RAC , some of .whom have served on IBCs , also note that providing IBCs some discretion . in whether to review certain low risk clinical trials is desirable .", "label": "", "metadata": {}, "score": "56.32213"}
{"text": "data emerges .The determination of whether a trial meets this exemption from IBC .review should be made by the local IBCs .The initial trial , whether .", "label": "", "metadata": {}, "score": "56.414787"}
{"text": "As indicated in Section 2 , the STAR-2 study was implemented through three separate waves to allow for adequate oversight and assistance by the ISRN Coordinating Center .", "label": "", "metadata": {}, "score": "56.522835"}
{"text": "The level of review conducted and the time for this review by the local IRB were a concern for the ISRN Coordinating Center going into the implementation of this study .", "label": "", "metadata": {}, "score": "56.596294"}
{"text": "This change is intended to help meet the growing needs of BloodCenter researchers .Projects Deferred to NCI - CIRB .Per 45 CFR 46.114 , an institution participating in a cooperative project may enter into a joint review arrangement in an effort to avoid duplication of effort .", "label": "", "metadata": {}, "score": "57.020218"}
{"text": "These projects will still be required to use the appropriate MCW ICF Template : A - NCI to ensure local requirements and HIPAA authorizations are incorporated .", "label": "", "metadata": {}, "score": "57.10814"}
{"text": "With the need to disseminate best practices , publication of quality improvement activities is warranted ; however , many journals and publishers will not publish original data if the project was not approved by an accredited institutional review board .", "label": "", "metadata": {}, "score": "57.163044"}
{"text": "Once a clinical research study is approved , the IRB tracks any complications or adverse events that may occur .Severe adverse events that may jeopardize the safety of patients involved in a study are immediately identified and reported to the IRB .", "label": "", "metadata": {}, "score": "57.245644"}
{"text": "Biosafety Risk and are Eligible for Exemption from IBC Review under .Section III - C-1 .This list can be updated by the NIH OBA , in .", "label": "", "metadata": {}, "score": "57.351967"}
{"text": "The IRB of the study site that did not pursue independent review accepted the UTHSCSA IRB approval and signed an investigator agreement to fall under the UTHSCSA FWA .", "label": "", "metadata": {}, "score": "57.45097"}
{"text": "However , based on the results of this report , there were many similarities between IRBs with regard to the level of review and time to approval .", "label": "", "metadata": {}, "score": "57.456917"}
{"text": "Amendments .Any change to what has been IRB approved must be submitted for review and approval by the IRB PRIOR to implementation .Such changes include : revision , deletion , or addition to the protocol ; modification to the recruitment or consent documents ; changes in study personnel ; change or addition of sponsor(s ) .", "label": "", "metadata": {}, "score": "57.58574"}
{"text": "for exempting review of subsequent protocol(s ) must have been conducted .in the same country .This will also ensure that an IBC in the country . in which the trial will be conducted has carried out a review of the . product .", "label": "", "metadata": {}, "score": "57.714592"}
{"text": "the health and safety of the subject , health care worker , and .community .IBCs play a critical role in the evaluation of new products and .", "label": "", "metadata": {}, "score": "57.916603"}
{"text": "a determination regarding whether the trial meets the exemption .criteria .It would not make sense to set up an IBC solely to determine .", "label": "", "metadata": {}, "score": "57.98677"}
{"text": "within 10 working days to the NIH Director , the Principal .Investigator , the sponsoring institution , and other DHHS components , . as appropriate , summarizing the RAC recommendations .", "label": "", "metadata": {}, "score": "58.073856"}
{"text": "Insufficient time to obtain IRB approval .Committee Determinations .Review by the convened IRB results in one of the following decisions and is subsequently communicated to the Principal Investigator in writing : .", "label": "", "metadata": {}, "score": "58.19213"}
{"text": "Methods .Protocol Fidelity .To assure that scientific rigor and protocol fidelity were maintained , the ISRN Coordinating Center , housed in the Academic Center for Evidence - Based Practice at UTHSCSA , coordinated this project .", "label": "", "metadata": {}, "score": "58.32628"}
{"text": "conducted using the same gene transfer product .This initial trial may . not be a single subject protocol or what is sometimes referred to as a . ''", "label": "", "metadata": {}, "score": "58.348236"}
{"text": "Protocol RTBSE-11-(N ) .1995S-0158 Vol .49 Sup .Northfield Laboratories Inc.Public disclosure information re : institutional review boards , Detroit Receiving Hospital ( Detroit , MI ) and Sinai - Grace Hospital ( Detroit , MI ) .", "label": "", "metadata": {}, "score": "58.37378"}
{"text": "With the landmark report from the Institute of Medicine indicating the need to transform the healthcare system [ 2 ] , quality improvement research must go beyond the single site , single investigator mindset .", "label": "", "metadata": {}, "score": "58.530922"}
{"text": "It can be concluded that providing these previously approved documents as templates , site - specific IRB reviews were able to be completed in a shorter amount of time , resulting in quicker study startup .", "label": "", "metadata": {}, "score": "58.588165"}
{"text": "The design of the proposed .trial should be comparable to the previous clinical study that is being .used to justify an exemption from IBC review .", "label": "", "metadata": {}, "score": "58.817474"}
{"text": "The delay in study submission may be attributed to a lack of clear definitions and differing interpretations of the regulations that challenge researchers .Introduction .", "label": "", "metadata": {}, "score": "58.825783"}
{"text": "This action by OHRP greatly changed the way quality improvement is viewed .The purpose of this report is to provide an ad hoc , descriptive review of the process required to obtain IRB approvals for the implementation of a multisite , quality improvement study .", "label": "", "metadata": {}, "score": "58.964256"}
{"text": "Policies and Procedures .The ethical commitment and practices of the institution are defined by policies and procedures that guide its research community with regard to human subject protections .", "label": "", "metadata": {}, "score": "59.104828"}
{"text": "If you answer yes to any of the below , Investigators must create and submit their project to the MCW / FH Institutional Review Board for review and approval prior to beginning the work .", "label": "", "metadata": {}, "score": "59.586998"}
{"text": "be required for gene transfer protocols that meet all of the . following criteria : .( 1 ) A previous clinical trial using this investigational gene .", "label": "", "metadata": {}, "score": "59.61673"}
{"text": "Hospital M 's IRB goes as far as having an online checklist to determine if the research projects require IRB approval .To facilitate a quick approval from each of the study sites at the onset of the STAR-2 study , each site was encouraged to sign investigator agreements to fall under the federalwide assurance of the parent IRB at the UTHSCSA .", "label": "", "metadata": {}, "score": "59.756554"}
{"text": "IRB regulations require at least annual monitoring of all projects , although the IRB may prescribe more frequent monitoring based on risk assessment .One year from the date of your IRB approval , you will be required to complete an annual IRB Continuing Review Form .", "label": "", "metadata": {}, "score": "59.8599"}
{"text": "In general , the secondary analysis of existing data only requires IRB review when it falls under the regulatory definition of research and human subjects .", "label": "", "metadata": {}, "score": "60.271164"}
{"text": "All subjects had normal range personality and intelligence and were able to perform the task well .Our research protocol was approved by the institutional review board at Huntington Memorial Hospital , Pasadena , CA , and informed consent was obtained from each the subjects .", "label": "", "metadata": {}, "score": "60.284702"}
{"text": "Language and culture must be taken into consideration and , when necessary , translated consent documents must be used or an impartial translator / interpreter provided .", "label": "", "metadata": {}, "score": "60.38546"}
{"text": "Figure 1 depicts the schematic for IRB approval process for the ISRN .Data Collection on IRB Variation .Using the IRB application , correspondence , and approval letters as data , we identified the level of review conducted ( exempt , expedited , or full board ) and noted any changes that were made in the final approved documents relative to the standardized protocol and consent form .", "label": "", "metadata": {}, "score": "60.481583"}
{"text": "site ) ; ( 2 ) Institutional Review Board approval ; ( 3 ) Institutional .Review Board - approved informed consent document ; ( 4 ) curriculum .", "label": "", "metadata": {}, "score": "60.52151"}
{"text": "site ) ; ( 2 ) Institutional Review Board approval ; ( 3 ) Institutional .Review Board - approved informed consent document ; ( 4 ) curriculum .", "label": "", "metadata": {}, "score": "60.52151"}
{"text": "The following are examples of ancillary committee which may need to review a submission prior to IRB review : .Submitting Changes to a Study .", "label": "", "metadata": {}, "score": "60.64762"}
{"text": "Thirteen of the 14 IRBs conducted independent reviews of the project .Twelve IRBs approved the study through expedited review while two IRBs reviewed the project at a full board meeting .", "label": "", "metadata": {}, "score": "60.884922"}
{"text": "The samples will be used in several Institutional Review Board ( IRB)-approved Laboratory of Allergic Diseases ( LAD ) protocols .This protocol is designed to assure adequate and complete informed consent , counseling , and protection of the study subjects according to IRB , Office of Human Subjects Research ( OHSR ) , Office for Human Research Protections ( OHRP ) and other applicable Federal regulatory standards .", "label": "", "metadata": {}, "score": "61.081066"}
{"text": "The samples will be used in several Institutional Review Board ( IRB)-approved Laboratory of Allergic Diseases ( LAD ) protocols .This protocol is designed to assure adequate and complete informed consent , counseling , and protection of the study subjects according to IRB , Office of Human Subjects Research ( OHSR ) , Office for Human Research Protections ( OHRP ) and other applicable Federal regulatory standards .", "label": "", "metadata": {}, "score": "61.081066"}
{"text": "The institution may also set its . own policies regarding the need for the PI to inform the IBC about . enrollment , any relevant new biosafety findings , and completion of the . trial .", "label": "", "metadata": {}, "score": "61.106762"}
{"text": "These documents have been developed by eBridge Support in collaboration with the MCW / FH IRB Office .Finally Investigators will be required to inform the Institution or MCW / FH IRB Office ( via eBridge ) in addition to NCI - CIRB of the following changes or events which may occur during the conduct of the project : .", "label": "", "metadata": {}, "score": "61.32729"}
{"text": "Phase II or Phase III trials , the policy focuses instead on having data .from at least one comparable trial .The NIH OBA also recognizes that .", "label": "", "metadata": {}, "score": "61.438248"}
{"text": "Institutions with IBCs should . establish a policy for how to handle protocols that are eligible for .exemption .An IBC may require that the PI at that site or the sponsor . register and provide an abbreviated summary of the data from the first . trial to confirm that the trial indeed meets the exemption criteria .", "label": "", "metadata": {}, "score": "61.598167"}
{"text": "The Full Board Committee is required to review any research that is more than minimal risk .The committee meets approximately once a month during the academic school year to conduct IRB business .", "label": "", "metadata": {}, "score": "61.65898"}
{"text": "Protocol RTBSE-11-(N ) .1995S-0158 Vol .51 Sup .Northfield Laboratories Inc.Public disclosure information re : institutional review boards , Albany Medical Center ( Albany , NY ) and University of Kansas Medical Center ( Kansas City , KS ) .", "label": "", "metadata": {}, "score": "61.720726"}
{"text": "An interim analysis or safety monitoring report indicates that the frequency or magnitude of harms or benefits might be different from those initially presented to the IRB .", "label": "", "metadata": {}, "score": "61.732952"}
{"text": "An extension request must be approved by the IRB before continuing the study beyond the project approval period .The IRB requests that these continuing review forms be submitted 30 days prior to protocol expiration .", "label": "", "metadata": {}, "score": "61.923054"}
{"text": "In selecting subjects , distribute the burdens and benefits of research equally among the various segments of society .Review Criteria .The IRB follows these national standards of criteria for review and approval of human research : .", "label": "", "metadata": {}, "score": "61.936596"}
{"text": "process .However , the NIH OBA recognizes that such labels are not all . inclusive and there may be Phase I / II trials that follow an initial . safety study .", "label": "", "metadata": {}, "score": "62.119583"}
{"text": "Provision will be made for monitoring the data to protect subjects .The privacy and confidentiality of the subjects will be protected , as well as their rights and welfare .", "label": "", "metadata": {}, "score": "62.27279"}
{"text": "Requirements for Reporting to the IRB .The purpose of prompt reporting is to ensure that appropriate steps are taken in a timely manner to protect subjects from avoidable harm .", "label": "", "metadata": {}, "score": "62.379242"}
{"text": "Protocol RTBSE-11-(N ) .1995S-0158 Vol .45 Sup .Northfield Laboratories Inc.Public disclosure information re : institutional review board , The Medical Center of Central Georgia ( Macon , GA ) .", "label": "", "metadata": {}, "score": "62.52319"}
{"text": "and was reviewed by an Institutional IBC and is now complete .( 2 )The investigational gene transfer agent uses a plasmid or . viral vector derived from a virus listed in Appendix B - V-2 that is : .", "label": "", "metadata": {}, "score": "62.596115"}
{"text": "If more significant problems are identified , the IRB may stipulate how such issues will be resolved .If more significant problems are identified , the IRB may stipulate how such issues will be resolved .", "label": "", "metadata": {}, "score": "62.852985"}
{"text": "IRB review processes are governed by Federal regulations which provide for both convened board and administrative review mechanisms .The IRB Chair makes the final determination for the level of review if a question arises and may upgrade the level of review if in the best interest of human subject protection .", "label": "", "metadata": {}, "score": "62.869545"}
{"text": "above criteria , be they single or multisite trials .The NIH OBA has used the terms Phase II and Phase III in this . notice to describe the type of trial that would be exempt under this . new policy .", "label": "", "metadata": {}, "score": "63.023617"}
{"text": "The consent form for each site must be reviewed and approved by the MCW / FH IRB before enrolling subjects at that site .BloodCenter of Wisconsin has contracted with the Medical College of Wisconsin ( MCW ) for IRB services .", "label": "", "metadata": {}, "score": "63.102535"}
{"text": "Submitting Continuing Progress Reports .In accordance with HHS and FDA regulations 45 CFR 46.109(e ) , 21 .CFR 56.109(f ) , a continuing progress report must be submitted for review and approval at intervals appropriate to the degree of risk , but not less than once per year .", "label": "", "metadata": {}, "score": "63.1193"}
{"text": "The purpose of this paper is to report the variance in institutional review board ( IRB ) reviews as part of the implementation of a multisite , quality improvement study through the Improvement Science Research Network ( ISRN ) and recommend strategies successful in procuring timely IRB approval .", "label": "", "metadata": {}, "score": "63.547283"}
{"text": "Samples provided through this protocol will be used solely for in vitro research .Blood , bone marrow , and buccal mucosa samples will be assigned a unique product number and the study investigators listed on this protocol will serve as the custodians of the code that links the product with a donor s identity .", "label": "", "metadata": {}, "score": "63.66875"}
{"text": "Its decisions may be modified by institutional officials to be more restrictive , but not less so .The IRB is duly constituted to reflect the institution 's research climate with both experience and expertise and is registered with the U.S. Office for Human Subject Research Protection ( IRB#0000383 ) .", "label": "", "metadata": {}, "score": "63.714256"}
{"text": "( 3 )The previous clinical trial : .a. Was conducted in the same country as the proposed trial ; .b. Enrolled a comparable population in terms of age ( i.e. adult .", "label": "", "metadata": {}, "score": "63.867367"}
{"text": "the local clinical environment .The IBC also examines the preclinical .data that support the safety of the vector as delivered .Finally , the .", "label": "", "metadata": {}, "score": "63.88686"}
{"text": "The . initial study should have been conducted in the same country as the .proposed study to control for potential variability in infectious .disease backgrounds of the participants .", "label": "", "metadata": {}, "score": "63.99269"}
{"text": "First , this is a descriptive study of 14 hospital IRBs evaluating one study and thus the results of this study may not be generalizable .", "label": "", "metadata": {}, "score": "64.252014"}
{"text": "Completion of the IRB application is a necessary yet time - consuming process [ 4 ] .The ISRN has developed a streamlined approach to facilitate IRB submissions at the local site through the use of the protocol implementation kit ( PIK ) .", "label": "", "metadata": {}, "score": "64.26094"}
{"text": "IBC registered with the OBA .This initial trial will have established .the safety of the proposed dose of the gene transfer product ( vector .", "label": "", "metadata": {}, "score": "64.421295"}
{"text": "Frequency of review is determined by the IRB upon initial review and each subsequent continuing progress report review .Is my project considered \" multi - site \" ?", "label": "", "metadata": {}, "score": "64.94511"}
{"text": "4 , pp .33 - 39 , 2012 .View at Google Scholar .P. M. Palevsky , M. S. Washington , J. A. Stevenson et al . , \" Improving compliance with the dialysis prescription as a strategy to increase the delivered dose of hemodialysis : an ESRD Network 4 quality improvement project , \" Advances in Renal Replacement Therapy , vol .", "label": "", "metadata": {}, "score": "65.02121"}
{"text": "multisite trials that follow an initial Phase I safety trial or a Phase .II study by removing the requirement for multiple IBC reviews for a .", "label": "", "metadata": {}, "score": "65.02964"}
{"text": "shall submit the following documentation to NIH OBA : ( 1 )A copy of .the informed consent document approved by the Institutional Review .", "label": "", "metadata": {}, "score": "65.31999"}
{"text": "After that , the submission will be dismissed and you will need to reapply .When your project is approved , you will receive written confirmation from the IRB that you are cleared to proceed with your participant recruitment and data collection .", "label": "", "metadata": {}, "score": "65.32138"}
{"text": "Its primary responsibility is the protection of subjects from undue risk and from deprivation of personal rights and dignity .This protection is guided by the ethical principles set forth in the Declaration of Helsinki of the World Medical Association and the \" Belmont Report \" ( Ethical Principles for the Protection of Human Subjects in Research ) .", "label": "", "metadata": {}, "score": "65.461784"}
{"text": "g )Planned Protocol Deviation which increases the risk to participants or others , decrease potential benefits of the study , or undermines the scientific integrity of the study .", "label": "", "metadata": {}, "score": "65.505875"}
{"text": "Twelve of the 14 ( 86 % ) study sites obtained IRB approval through an expedited process , with the remaining two study sites having the study go to full board review .", "label": "", "metadata": {}, "score": "65.742584"}
{"text": "When an Investigator receives an amendment or a request for change to the approved project , they must submit the amendment promptly to secure final IRB approval within 90 days from notification of the change .", "label": "", "metadata": {}, "score": "65.85934"}
{"text": "Table 2 provides data on the approval timelines for time to submission , time to approval , and time to study start .On average , the 14 study sites submitted the project to their IRB 45.1 \u00b1 31.8 days after receiving the study related documents , received approval 14.3 \u00b1 5.7 days after submission , and started the study 29.9 \u00b1 10.1 days after receiving IRB approval .", "label": "", "metadata": {}, "score": "65.892365"}
{"text": "If changes to the consent documents are required , include revised consent / assent forms with changes highlighted .Include a copy of any documents requested by the committee and highlight any changes made in response to stipulations .", "label": "", "metadata": {}, "score": "65.90004"}
{"text": "This progress will raise the scientific rigor of these improvement initiatives and will facilitate spread and uptake of effective improvement strategies .Furthermore , with this evolution , challenges have arisen for regulatory agencies , IRBs , and researchers to keep up to date on the interpretation of the regulatory guidances as part of the improvement research initiative .", "label": "", "metadata": {}, "score": "66.02063"}
{"text": "The NPRM seeks comments on proposals to better protect human subjects involved in research , while facilitating valuable research and reducing burden , delay , and ambiguity for investigators .", "label": "", "metadata": {}, "score": "66.10443"}
{"text": "All active research studies are subject to formal continuing review by the IRB panel , on an annual basis , or more frequently in studies that involve greater than minimal risk to those enrolled .", "label": "", "metadata": {}, "score": "66.11841"}
{"text": "this exemption to trials that would be conducted at more than one site , . including at sites that might not already have an IBC .", "label": "", "metadata": {}, "score": "66.152794"}
{"text": "Events which meet MCW 's Prompt Reporting Criteria . a )Any Adverse Events ( internal or external ) that meet all of these criteria : .", "label": "", "metadata": {}, "score": "66.27928"}
{"text": "Not performing a specific screening procedure for a patient as indicated in the protocol .Examples include but are not limited to the following .QI routine review reports which recommended immediate reporting of events .", "label": "", "metadata": {}, "score": "66.298096"}
{"text": "Tabled : Significant outstanding issues were identified that can not be resolved by IRB stipulations to the proposed research and must be resubmitted for further review .", "label": "", "metadata": {}, "score": "66.40636"}
{"text": "consider whether a proposed human gene transfer experiment presents .characteristics that warrant public RAC review and discussion ( See .Appendix M - I - B-2 ) .", "label": "", "metadata": {}, "score": "66.577324"}
{"text": "Quality improvement may be successful within a single unit or hospital ; however , the limiting factor with single site quality improvement projects is that it may not yield generalizable knowledge that can be implemented into clinical settings [ 1 , 3 ] .", "label": "", "metadata": {}, "score": "66.63931"}
{"text": "For other agents that interfere with blood clotting without prolonging the PT , a 7-day washout period will be required before bone marrow sampling .", "label": "", "metadata": {}, "score": "66.67531"}
{"text": "IRB Continuing Review .On - going review of approved studies is conducted by the IRB as the research progresses to monitor for safety and effectiveness .", "label": "", "metadata": {}, "score": "66.7318"}
{"text": "the NIH OBA .If the sponsor or a site investigator concludes that their . trial meets the exemption criteria , this should be confirmed by at .", "label": "", "metadata": {}, "score": "66.743256"}
{"text": "Exempt Certification .Studies involving minimal risk AND fitting one of four specific categories may be exempted from annual reporting requirements .However , the investigator must apply to the IRB for certification of exemption and review for compliance with other applicable institutional policies and procedures .", "label": "", "metadata": {}, "score": "66.744965"}
{"text": "If you allow your protocol to expire , all data collection must stop and a new application must be submitted to continue the human subjects research .", "label": "", "metadata": {}, "score": "66.90323"}
{"text": "However , based upon federal regulations for HIPAA at 45 CFR 46.160 and 164 , a review by the Institution 's Privacy Board is required .", "label": "", "metadata": {}, "score": "66.94674"}
{"text": "Review .Review by the convened board is required for all studies involving greater than minimal risk or which do not qualify for administrative review ( See Exempt or Expedited , below ) .", "label": "", "metadata": {}, "score": "67.02512"}
{"text": "Describe the study fully .Point out foreseeable risks or discomforts .Explain anticipated benefits .Explain alternatives .Describe how confidentiality will be maintained .", "label": "", "metadata": {}, "score": "67.03328"}
{"text": "Table 1 describes the type of IRB used , type of review conducted , and whether documented consent was required .Approval Timelines .The STAR-2 multisite study was implemented in three waves with two study sites in wave 1 and 6 study sites each in waves 2 and 3 , respectively .", "label": "", "metadata": {}, "score": "67.14757"}
{"text": "Specifically , the NIH OBA proposes to remove the requirement that . institutional biosafety committees ( IBCs ) review and approve certain .human gene transfer clinical trials that use plasmids and certain . attenuated , non - integrating viral vectors , provided the clinical trial .", "label": "", "metadata": {}, "score": "67.360565"}
{"text": "The NIH OBA . recognizes that the biosafety profiles of many vectors are well . characterized , and while the transgene may have an impact on the safety .", "label": "", "metadata": {}, "score": "67.36761"}
{"text": "a human gene transfer experiment , the Principal Investigator(s ) .shall submit the following documentation to the NIH OBA : ( 1 )A copy . of the informed consent document approved by the Institutional .", "label": "", "metadata": {}, "score": "67.455475"}
{"text": "CONCLUSION :The use of a toxicology screening protocol at birth appears beneficial in determining the need for identifying infants with NAS .Early detection of substance exposure in newborns leads to timely assessment for NAS and subsequent treatment to reduce symptoms in newborns .", "label": "", "metadata": {}, "score": "67.84067"}
{"text": "The new .proposed language is as follows : .For a clinical trial site that is added after the RAC review .process , no research participant shall be enrolled ( see definition . of enrollment in Section I - E-7 ) at the clinical trial site until the . following documentation has been submitted to the NIH OBA : ( 1 ) .", "label": "", "metadata": {}, "score": "67.96646"}
{"text": "an exemption from further IBC review , the NIH OBA considered the types . of vectors that have been frequently used in gene transfer protocols . over a number of years .", "label": "", "metadata": {}, "score": "67.98577"}
{"text": "Discussion .The purpose of this paper was to document variation in IRB review in the implementation of the STAR-2 multisite study conducted and coordinated by the ISRN .", "label": "", "metadata": {}, "score": "68.046295"}
{"text": "These templates were based on the initial submission made by the ISRN Coordinating Center to the UTHSCSA IRB .By providing an IRB template , the site PIs and research associates simply had to modify certain components of the application specific to their IRB and were able to submit the IRB application as soon as 2 days after receiving the PIK .", "label": "", "metadata": {}, "score": "68.27038"}
{"text": "Notice : .The U. S. Department of Health and Human Services ( HHS ) has announced a proposal to improve rules protecting human research subjects .", "label": "", "metadata": {}, "score": "68.447"}
{"text": "In the event that the certification lapses , the principal investigator will ensure that uncertified personnel do not participate in the study until certification is renewed .", "label": "", "metadata": {}, "score": "68.47827"}
{"text": "In total , 716 nurses participated from the 41 units involved in this study .This study start was staggered and broken into three waves .", "label": "", "metadata": {}, "score": "68.57567"}
{"text": "The convened IRB usually meets twice a month ( see IRB Calendar ) .Unscheduled meetings may be called at the IRB Chair 's discretion , and are subject to all standards of a routine IRB meeting , including requirements for a quorum .", "label": "", "metadata": {}, "score": "68.86931"}
{"text": "View the OHRP Informed Consent FAQs here .All research involving human participants ( subjects ) must be reviewed and approved by the University 's IRB before you begin collecting data .", "label": "", "metadata": {}, "score": "68.88153"}
{"text": "An initial safety trial , or Phase I trial , . may be used to support the exemption of a Phase II trial while an . initial safety trial , Phase I , or a Phase II trial may be used to .", "label": "", "metadata": {}, "score": "68.9019"}
{"text": "Because an incorrect guess by the investigator might have serious consequences , proposals that may not meet criteria for human subject research should be submitted in eBridge or via our paper application for IRB determination .", "label": "", "metadata": {}, "score": "68.92363"}
{"text": "Institutional Review Board - approved informed consent document ; ( 4 ) .curriculum vitae of the Principal Investigator(s ) ( no more than two . pages in biographical sketch format ) ; and ( 5 ) NIH grant number(s ) if . applicable .", "label": "", "metadata": {}, "score": "68.99151"}
{"text": "Institutional Review Board - approved informed consent document ; ( 4 ) .curriculum vitae of the Principal Investigator(s ) ( no more than two . pages in biographical sketch format ) ; and ( 5 ) NIH grant number(s ) if . applicable .", "label": "", "metadata": {}, "score": "68.99151"}
{"text": "The extremely low number of investigator agreements perhaps is due to oversight pressures felt by local IRBs to govern and regulate studies conducted at their respective institutions and an increase in regulatory actions [ 19 ] .", "label": "", "metadata": {}, "score": "69.086426"}
{"text": "In addressing its mission , the ISRN 's infrastructure is tailored to conduct multisite improvement research to produce generalizable knowledge .Previous publications have documented variations of IRB review for research networks engaged in multisite clinical trials [ 4 , 11 - 15 ] .", "label": "", "metadata": {}, "score": "69.09819"}
{"text": "Vulnerable subjects , such as children , must be adequately protected .The Informed Consent Process .One of the most important requirements imposed by the IRB in research involving patients is the informed consent process .", "label": "", "metadata": {}, "score": "69.099625"}
{"text": "The IRB watches over clinical research at HSS , with the primary responsibility of assuring that in the conduct of meaningful clinical research , the highest ethical standards and scientific integrity are maintained .", "label": "", "metadata": {}, "score": "69.336685"}
{"text": "For the subsequent .trials using the same agent , if they will be conducted only at sites .that receive NIH funding for recombinant or synthetic nucleic acid .", "label": "", "metadata": {}, "score": "69.467545"}
{"text": "Under very limited circumstances , the U.S. Food and Drug Administration allows use of an investigational drug or device without IRB pre - approval for treatment of a patient .", "label": "", "metadata": {}, "score": "69.495865"}
{"text": "For a clinical trial site that is added after the RAC review .process , no research participant shall be enrolled ( see definition . of enrollment in Section I - E-7 ) at the clinical trial site until the . following documentation has been submitted to NIH OBA : ( 1 ) .", "label": "", "metadata": {}, "score": "69.53458"}
{"text": "biosafety of gene transfer trials .DATES :All comments should be submitted by June 12 , 2013 .ADDRESSES : Comments may be submitted to the NIH OBA by email at oba@od.nih.gov ; by fax to 301 - 496 - 9839 ; or by mail to the NIH Office of .", "label": "", "metadata": {}, "score": "69.93386"}
{"text": "The greatest delay in approval was seen early on in the IRB process with site PIs averaging 45.1 \u00b1 31.8 days to submit the study to the IRB .", "label": "", "metadata": {}, "score": "70.0439"}
{"text": "Institutional Review Board oversight and regulatory review is provided by a panel of 12 full - time members and 10 alternates .The members are professionally diverse , consisting of doctors , nurses , and professional staff representing expertise in all areas of scientific review .", "label": "", "metadata": {}, "score": "70.0744"}
{"text": "Can MCW investigators use a different IRB ?If an investigator wishes MCW to rely upon a non - MCW IRB for review and approval of a study , the investigator must first submit a request to the MCW HRPP Office .", "label": "", "metadata": {}, "score": "70.29488"}
{"text": "The Role of the IRB .The primary role of the Institutional Review Board ( IRB ) is to ensure ethical treatment of research participants .", "label": "", "metadata": {}, "score": "70.29818"}
{"text": "Therefore it 's important that the forms are completed entirely to allow the MCW HRPP Office to make a decision .Questions regarding MCW / FH IRB oversight jurisdiction should come to the MCW HRPP Office .", "label": "", "metadata": {}, "score": "70.33864"}
{"text": "1988 with the OBA .While the majority of trials are still small safety . studies , increasingly Phase II and III multisite trials are being . initiated .", "label": "", "metadata": {}, "score": "70.39769"}
{"text": "The ISRN and the site PIs collaborated on ways to reduce undue influence by supervisors during the consent process .Working with the site PIs and their local IRB , a decision was made requiring supervisors not be involved in the consenting process .", "label": "", "metadata": {}, "score": "70.604485"}
{"text": "IRB official files are retained for at least 3 years after completion of the research .Such records will be accessible for inspection by authorized representatives of the institution , federal agencies , and sponsors .", "label": "", "metadata": {}, "score": "70.79195"}
{"text": "Hospital A 's IRB of record chose to sign an investigator agreement falling under the regulatory oversight to the UTHSCSA IRB .Hospital B 's IRB of record was a part of the faculty senate consisting of an IRB chair , 7 scientific reviewers , and one public reviewer .", "label": "", "metadata": {}, "score": "71.35257"}
{"text": "The NIH OBA . recognizes that there are many clinical factors that affect the safety . of a product in a certain population , including co - morbidities and type . of disease .", "label": "", "metadata": {}, "score": "71.40333"}
{"text": "Continued oversight by an IBC to ensure .proper handling and administration of vaccinia vectors seems prudent .Clinical research with integrating vectors , including transposons , is .", "label": "", "metadata": {}, "score": "71.45041"}
{"text": "To submit comments during the public comment period , visit : .When is IRB Review Required ?( 2 ) Collection of identifiable private data on living individuals and/or .", "label": "", "metadata": {}, "score": "71.50623"}
{"text": "To complete this project , ISRN PIs partnered with 14 hospitals from across the country .Each site , led by a site PI , engaged nurses from three medical - surgical units to self - report operational failures encountered in routine care , in real time , using an index sized \" Pocket Card \" for 10 shifts over 20 days .", "label": "", "metadata": {}, "score": "71.736176"}
{"text": "The IRB is interested in making the IRB review process more efficient whenever possible .To that end , the MCW / FH IRB has developed a robust reliance system which includes policies and procedures through which certain types of studies may be eligible for review by a single IRB .", "label": "", "metadata": {}, "score": "71.80141"}
{"text": "By . continuing to require registration and reporting on these trials , the .NIH OBA will be able to continue to monitor adverse events or incident . reports of accidental exposures by health care workers delivering these . agents and , if necessary , provide information regarding these events to . investigators , IBCs , and the public .", "label": "", "metadata": {}, "score": "71.86209"}
{"text": "Public RAC review and discussion of a human gene transfer .experiment may be : ( 1 ) Initiated by the NIH Director ; or ( 2 ) .", "label": "", "metadata": {}, "score": "71.908005"}
{"text": "Clinical trial conducted at numerous sites , even if all sites obtain IRB approval independently of each other .If you are uncertain if your project is considered \" multi - site \" , contact the MCW HRPP Office for guidance at IRBOffice@mcw.edu .", "label": "", "metadata": {}, "score": "71.94739"}
{"text": "This decision may include stipulations limiting IRB approval .Conditionally Approved : Changes are specified that require only the concurrence of the principal investigator or non - substantive clarifications that , when met , will allow the release of IRB approval .", "label": "", "metadata": {}, "score": "71.952805"}
{"text": "that do not have IBCs .In this situation , the NIH OBA expects the . individual responsible for the conduct of the trial to confirm with an . established IBC at one of the institutions that their trial does not . require IBC review before initiating the trial at a site that does not . have an IBC .", "label": "", "metadata": {}, "score": "72.51123"}
{"text": "All the following conditions must be met , documented , and reported to the IRB ( see Emergency Use Form ): .A life - threatening situation .", "label": "", "metadata": {}, "score": "72.52585"}
{"text": "The IRB must uphold HIPAA protection when considering how researchers may gain access to , use , and safeguard protected health information ( PHI ) necessary to conduct research .", "label": "", "metadata": {}, "score": "72.55322"}
{"text": "e ) Report from a Data Safety Monitoring Board ( DSMB ) or Equivalent if the report describes new information regarding risks or unanticipated problems involving risks .", "label": "", "metadata": {}, "score": "72.75514"}
{"text": "b ) Follow - up reports to initially reported Adverse Events which meet all of the above criteria .c ) Unanticipated Problems or any incident , experience , or outcome that meets all of the following criteria : .", "label": "", "metadata": {}, "score": "72.99971"}
{"text": "However , multiple publications have documented variations of IRB review for research networks , similar to the ISRN , engaged in multisite improvement projects [ 4 , 11 - 13 ] .", "label": "", "metadata": {}, "score": "73.07128"}
{"text": "Complaint of a subject when the complaint indicates unexpected risks or can not be resolved by the research team .d ) Safety Notice / Report from Sponsor or Central Site if report describes new information regarding risks or unanticipated problems involving risks .", "label": "", "metadata": {}, "score": "73.141235"}
{"text": "Sponsor imposed suspension for risk .Change in FDA labeling or withdrawal from marketing of a drug , device , or biologic used in a research protocol .", "label": "", "metadata": {}, "score": "73.17883"}
{"text": "each trial site , even if the site does not receive funding from NIH for .recombinant or synthetic nucleic acid research .However , there would .", "label": "", "metadata": {}, "score": "73.22278"}
{"text": "trials .Specifically , the dose(s ) of the gene transfer agent to be used .in the Phase II or III trial must be equal to or less than the dose .", "label": "", "metadata": {}, "score": "73.341385"}
{"text": "on the immune system .Consequently , if concomitant chemotherapy or .radiotherapy will be administered with the gene transfer agent , the co- .administration of these agents must have been tested in the initial . safety trial .", "label": "", "metadata": {}, "score": "73.341705"}
{"text": "What do I need to include in my IRB application for a multi - site study ?The breadth of information needed by the IRB is dependent upon the investigator 's role and will increase as the investigator 's responsibilities to the entire project increase .", "label": "", "metadata": {}, "score": "73.54591"}
{"text": "Therefore , no matter the level of risk involved in improvement science studies , there is a direct impact to patient safety and any delay in approving improvement science studies because of variance in IRB review directly impacts patient care .", "label": "", "metadata": {}, "score": "73.78729"}
{"text": "DO NOT begin recruiting participants or collecting data until IRB review is complete and you have received confirmation of approval .An IRB staff member will perform an initial review to determine that the application is complete and to determine what level of IRB review is required for the project .", "label": "", "metadata": {}, "score": "74.063614"}
{"text": "c. Tested a dose equal to or less than the dose proposed for the . new trial , using the same administration route and , if concomitant . interventions ( e.g. radiation and/or chemotherapy ) are proposed , .", "label": "", "metadata": {}, "score": "74.159744"}
{"text": "exemption of a trial using intravenous administration , as the . biodistribution of the product may be quite different .Chemotherapy , . radiation , and other immune modulatory agents can also potentially .", "label": "", "metadata": {}, "score": "74.2186"}
{"text": "The fifth paragraph of Section III - C-1 will be amended to add ' ' if . required ' ' at the end of the statement regarding IBC approval in order . to recognize that some trials will not need IBC review .", "label": "", "metadata": {}, "score": "74.38514"}
{"text": "Variations in Institutional Review Board Approval in the Implementation of an Improvement Research Study .Academic Center for Evidence - Based Practice , School of Nursing , University of Texas Health Science Center at San Antonio , MSC 7949 , 7703 Floyd Curl Drive , San Antonio , TX 78229 , USA .", "label": "", "metadata": {}, "score": "74.47032"}
{"text": "Examples include but are not limited to the following : .Any departure from the protocol ( deviation or violation ) that harmed subjects or others ; that indicates subjects or others might be at increased risk of harm ; or that compromises the integrity of the research data .", "label": "", "metadata": {}, "score": "74.48367"}
{"text": "The purpose of requesting the FDA .IND number is for facilitating interagency collaboration in the .federal oversight of human gene transfer research .Appendix M - I - C-2 will likewise be revised to recognize that not all .", "label": "", "metadata": {}, "score": "74.51978"}
{"text": "Undated .Page modified 2003 - 07 - 22 .What happened to the regulation that the IRB consider the opinions of community members during review and approval of a trial to be conducted under FDA exemption from requirements for informed consent ?", "label": "", "metadata": {}, "score": "74.86313"}
{"text": "Though limitations to this study exist , this report presents important review of how 14 IRBs review a single study .Furthermore , the multisite study presented in this report was a minimal risk study of nurses self - reporting system operational failures with no interactions with patients .", "label": "", "metadata": {}, "score": "74.97871"}
{"text": "The proposed Appendix M - I- .C-1 is as follows : .Appendix M - I - C-1 : Initiation of the Clinical Investigation .", "label": "", "metadata": {}, "score": "74.995026"}
{"text": "up ; therefore IBC oversight is again appropriate .A list of viruses eligible for this exemption will be presented in .a new section of Appendix B ( Appendix B - V-2 ) that will be titled .", "label": "", "metadata": {}, "score": "75.103806"}
{"text": "Review Boards .However , given the competing demands on IBCs , this . change will provide IBCs with the option of focusing their efforts on .", "label": "", "metadata": {}, "score": "75.216415"}
{"text": "\" The Privacy Rule , \" known as HIPAA , the \" Health Insurance Portability and Accountability Act , \" became effective in April , 2003 .", "label": "", "metadata": {}, "score": "75.37249"}
{"text": "It does not apply to basic , .nonclinical research .In addition , it does not create an exemption from .registration of the trial with the NIH OBA or the Recombinant DNA .", "label": "", "metadata": {}, "score": "75.42093"}
{"text": "( See Minor Actions in the NIH Guidelines Section IV - C-1-b-(2 ) . )As . experience grows with other vectors , they may also become eligible for .", "label": "", "metadata": {}, "score": "75.550095"}
{"text": "The Nuremberg Code standards coupled with subsequent experience and more insightful ethical values have resulted in eight fundamental principles that guide clinical research at HSS : .", "label": "", "metadata": {}, "score": "75.557816"}
{"text": "[ [ Page 27978 ] ] . can be submitted to the same email address or by fax to 301 - 496 - 9839 or .", "label": "", "metadata": {}, "score": "75.5872"}
{"text": "S.f .P.H.R. Participants .Washington , DC , USA , The National Academies Press , 2002 .Department of Health and Human Services , \" Office of Human Research Protection , \" 2012 . D. G. Graham , W. Pace , J. Kappus , et al . , \" Institutional Review Board Approval of Practice - based Research Network Patient Safety Studies Implementation Issues , \" 2005 .", "label": "", "metadata": {}, "score": "75.64348"}
{"text": "Research is defined by the U.S. Department Health and Human Services as \" a systematic investigation , including research development , testing and evaluation , designed to develop or contribute to generalizable knowledge . \"", "label": "", "metadata": {}, "score": "75.93332"}
{"text": "Principal Investigators wishing to acquire volunteer assistance must complete and submit the UW System Volunteer Agreement Form .This agreement is a standard form utilized by UW System to acquire volunteer help .", "label": "", "metadata": {}, "score": "75.999344"}
{"text": "Research is the engine that drives this academic excellence and the best patient care possible .While most patients understand the importance of research and are inclined to participate , it is natural to have some concerns about joining a clinical trial .", "label": "", "metadata": {}, "score": "76.43996"}
{"text": "If MCW is engaged in human subjects research , then IRB review of some type will be required .Oversight and jurisdiction of the MCW / FH IRB : .", "label": "", "metadata": {}, "score": "76.632126"}
{"text": "The guiding principles that are the core of research participant safeguards emerged after World War II , resulting in the Nuremberg Code of 1948 , a foundation of five basic human protections in clinical research : .", "label": "", "metadata": {}, "score": "76.96811"}
{"text": "41 , no . 1 , pp .214 - 230 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. A. Thompson , \" Variation in local institutional review board evaluations of a multicenter patient safety study , \" Journal for Healthcare Quality , vol .", "label": "", "metadata": {}, "score": "77.05258"}
{"text": "The PI or sponsor should consult .with the NIH OBA regarding whether the trial is exempt from review .To implement this exemption , the following proposed changes will be . made to Section III - C and to Appendices M - I - C-1 , M - I - C-2 , and B. The . current Section III - C-1 states : .", "label": "", "metadata": {}, "score": "77.09129"}
{"text": "Provide contacts who will share more information or discuss concerns .Explain that participation is voluntary and that the subject may withdraw at any time .", "label": "", "metadata": {}, "score": "77.10313"}
{"text": "there can be differences in the prevalence of certain infectious . diseases ; however , it is likely that those differences may be more .pronounced between different countries , as certain infectious diseases . are endemic in some countries but rarely observed in others .", "label": "", "metadata": {}, "score": "77.10618"}
{"text": "In selecting Hospital for Special Surgery ( HSS ) for your orthopedic and rheumatologic care , you are entering a hospital with a rich tradition of innovation and education that has long established HSS as an internationally recognized center of excellence for musculoskeletal health care .", "label": "", "metadata": {}, "score": "77.27988"}
{"text": "Institute of Medicine , Crossing the Quality Chasm : A New Health System for the 21st Century ( Committee on Health Care in America & Institute of Medicine ) , National Academies Press , Washington , DC , USA , 2001 .", "label": "", "metadata": {}, "score": "77.373215"}
{"text": "undue burden , as the gene transfer field advances and more Phase II and .Phase III multisite trials are developed , the time , effort and expense . associated with multiple IBC reviews can be significant without adding .", "label": "", "metadata": {}, "score": "77.428406"}
{"text": "transfer experiments .Public review and discussion of a human gene .transfer experiment ( and access to relevant information ) also serves . to inform the public about the technical aspects of the proposal , . meaning and significance of the research , and any significant .", "label": "", "metadata": {}, "score": "77.435036"}
{"text": "To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .For general information , see Learn About Clinical Studies .", "label": "", "metadata": {}, "score": "77.68532"}
{"text": "The main objective of this study was to analyze the consistency in using a standardized newborn toxicology screening protocol to identify infants at risk of developing neonatal abstinence syndrome ( NAS ) .", "label": "", "metadata": {}, "score": "77.73256"}
{"text": "The purpose of requesting the FDA IND number is for .facilitating interagency collaboration in the Federal oversight of .human gene transfer research .Appendix M I - C-1 would be amended to again recognize that IBC .", "label": "", "metadata": {}, "score": "77.74945"}
{"text": "Choice of reference did not affect the results .Although intracranial depth recordings mainly reflect local processing , it is possible that distant sources may also contribute to the observed activity .", "label": "", "metadata": {}, "score": "77.76906"}
{"text": "from the biological nature of the vector are clearly stated .Investigators have noted that repeated reviews by multiple IBCs of .a multisite Phase II or III trial have often not resulted in new . recommendations and such reviews can impose a cost on the research , . including the cost of establishing IBCs at sites without pre - existing .", "label": "", "metadata": {}, "score": "77.92152"}
{"text": "Furthermore , support and interactions from the ISRN Coordinating Center along with the Network PIs ( Stevens and Ferrer ) assisted in guiding the site PIs in the IRB process and working with individual IRB process and addressing questions regarding IRB issues .", "label": "", "metadata": {}, "score": "77.94845"}
{"text": "Institutional Review Board .The Institutional Review Board ( IRB ) operates under federal regulations , state laws , and institutional policy , reviewing all research involving human subjects to ensure the ethical and equitable treatment of those subjects .", "label": "", "metadata": {}, "score": "78.17582"}
{"text": "Any other lab value which may put the subject at risk during the procedure .Choosing to participate in a study is an important personal decision .", "label": "", "metadata": {}, "score": "78.62537"}
{"text": "The MCW HRPP Office reviews the form .If the form is incomplete , the form will be returned .The MCW HRPP Office will review the information and decide if the request will be considered .", "label": "", "metadata": {}, "score": "78.64784"}
{"text": "In some cases , a non - NIH - funded trial will be conducted both at . sites that receive NIH funding for recombinant or synthetic nucleic .", "label": "", "metadata": {}, "score": "78.694855"}
{"text": "By providing these templates and documents through the study PIK , each site PI simply needed to transcribe the provided information into their site specific IRB application forms .", "label": "", "metadata": {}, "score": "78.89395"}
{"text": "PATIENTS / PARTICIPANTS :Data were based on expectant mothers who delivered between March 2006 and March 2007 .METHOD : Data of maternal self - reported substance use , and urine toxicology results and meconium results were obtained through retrospective chart review of infants exhibiting signs of NAS as noted by nurses on the Finnegan Scoring Tool .", "label": "", "metadata": {}, "score": "78.90236"}
{"text": "The proposed Appendix M - I - C-2 is : .Appendix M - I - C-2 : Additional Clinical Trial Sites .No research participant shall be enrolled ( see definition of . enrollment in Section I - E-7 ) at a clinical trial site until the . following documentation has been submitted to the NIH OBA : ( 1 ) .", "label": "", "metadata": {}, "score": "79.02056"}
{"text": "It must be made by the MCW HRPP Office per policies and procedures .If an IRB Agreement is not already in place , an Agreement needs to be negotiated and fully signed before reliance can be finalized .", "label": "", "metadata": {}, "score": "79.03189"}
{"text": "This should be provided with the reliance request form to the MCW HRPP Office so that the form can be reviewed and any necessary changes to reflect local context can be requested .", "label": "", "metadata": {}, "score": "79.06819"}
{"text": "For studies involving member institutions in SEWIC , WIC , MARCH and GPC , see information below .What do I do if MCW decides to rely upon another IRB ?", "label": "", "metadata": {}, "score": "79.09712"}
{"text": "Everyone at HSS is dedicated to the highest standards of clinical research research that improves the lives of our patients .The HSS IRB is made up of knowledgeable and dedicated scientists and lay members who serve as an ethics review board for this research .", "label": "", "metadata": {}, "score": "79.17816"}
{"text": "Risks must be reasonable relative to the anticipated benefits of the study .The selection of research subjects must be equitable ( equal and fair ) and without bias .", "label": "", "metadata": {}, "score": "79.30016"}
{"text": "Principal investigators conducting research with decedents must submit an eBridge SmartForm application to the IRB for review and determination prior to conducting their research .BB IND 10719 Poly - SFH - P Injection [ Polymerized Human Hemoglobin ( Pyridoxylated ) , PolyHeme \u00ae . ]", "label": "", "metadata": {}, "score": "79.52969"}
{"text": "OBA by : ( a )Three or more RAC members ; or ( b ) a Federal agency other . than NIH .After a human gene transfer experiment is reviewed by the .", "label": "", "metadata": {}, "score": "79.546524"}
{"text": "transfer trials .IBCs identify and manage biosafety issues raised by .gene transfer agents , including safety issues that may arise due to the . nature of the vector .", "label": "", "metadata": {}, "score": "79.63324"}
{"text": "The ISRN was created through the National Institutes of Health funding in 2009 as a national research infrastructure to advance improvement research .The ISRN is made up of nearly 200 academicians and clinicians from across the country , a cyberinfrastructure supporting virtual collaboration , and a research coordinating center .", "label": "", "metadata": {}, "score": "79.754395"}
{"text": "All human research must be approved by the IRB .No research is exempt from review .IRB Submission Process .If you will be working with an existing human subjects dataset only , please complete an IRB Existing Data Form instead of the IRB Application Form .", "label": "", "metadata": {}, "score": "79.77779"}
{"text": "Possibly , probably , or definitely related to the research .Suggests the research places research participants or others at a greater risk of physical or psychological harm than was previously known or recognized .", "label": "", "metadata": {}, "score": "79.92764"}
{"text": "1995S-0158 Vol .26 Sup .Northfield Laboratories Inc.Public disclosure information re : institutional review boards , UCSD Medical Center ( San Diego , CA ) and Scripps Mercy Hospital ( San Diego , CA ) .", "label": "", "metadata": {}, "score": "80.064064"}
{"text": "Adverse Event and Problem Reporting : .Please direct any questions about the IRB process to IRB Chair Anca Miron at ( 920 ) 424 - 2328 or IRB Administration at 424 - 3215 or irb@uwosh.edu .", "label": "", "metadata": {}, "score": "80.21342"}
{"text": "In the absence of accurate prenatal screening , this study lends positively to support the use of toxicology screening protocols at birth to adequately assess and treat infants exposed to illicit substances .", "label": "", "metadata": {}, "score": "80.23677"}
{"text": "Official files include : [ FR Doc No : 2013 - 11222 ] .DEPARTMENT OF HEALTH AND HUMAN SERVICES .National Institutes of Health .", "label": "", "metadata": {}, "score": "80.42967"}
{"text": "New information that might affect adversely the safety of the participants or the conduct of the clinical trial .Any change significantly affecting the conduct of the clinical trial or increasing the risk to participants .", "label": "", "metadata": {}, "score": "80.552666"}
{"text": "Appendix M - I - C-2 now states : .Appendix M - I - C-2 : Additional Clinical Trial Sites .No research participant shall be enrolled ( see definition of . enrollment in Section I - E-7 ) at a clinical trial site until the . following documentation has been submitted to NIH OBA : ( 1 ) .", "label": "", "metadata": {}, "score": "80.62233"}
{"text": "Possibly , probably , or definitely related to participation in the research study , and .Suggests the research places subjects or others at greater risk of harm than was previously known or recognized .", "label": "", "metadata": {}, "score": "80.63819"}
{"text": "36 , no .4 , pp .S1-S40 , 2006 .View at Google Scholar \u00b7 View at Scopus .Institute of Medicine , \" Responsible Research : A Systems Approach to Protecting Research Participants , \" C.o .", "label": "", "metadata": {}, "score": "80.7015"}
{"text": "The risks are reasonable in relation to the benefits to the subject of the importance of the knowledge to be gained for humanity .The selection of subjects is equitable .", "label": "", "metadata": {}, "score": "80.75243"}
{"text": "Title 45 , part 46 of the Code of Federal Regulation ( CFR ) defines research as \" a systematic investigation , including research development , testing and evaluation , designed to develop or contribute to generalizable knowledge [ 6 ] . \"", "label": "", "metadata": {}, "score": "80.80012"}
{"text": "42 , no .6 , pp .646 - 654 , 2012 .View at Google Scholar .Department of Health and Human Services , \" Code of Federal Regulations Title 45 Public Welfare Part 46 : Protection of Human Subjects , current through Aug 2012 , \" D.o . H.a . H. Services , 2009 .", "label": "", "metadata": {}, "score": "81.24313"}
{"text": "Indeed , safety .data continue to emerge throughout the life cycle of a drug or biologic .agent , including after licensing .Nonetheless , given the experience .", "label": "", "metadata": {}, "score": "81.33107"}
{"text": "Appendix B - V-2 .Viruses Used in Vectors for Human Gene Transfer That .Present Low Biosafety Risk and Are Eligible for Exemption From IBC .", "label": "", "metadata": {}, "score": "81.50462"}
{"text": "Internal UPIRSOs that are not also AEs or SAEs , for example stolen laptop , security breach .Internal subject complaints .All audit reports from the MCW / FH site , including those from CIRB , cooperative groups , or the FDA .", "label": "", "metadata": {}, "score": "81.59836"}
{"text": "The HRPP Office and involved IRBs will make a decision about whether reliance is possible and which IRB should review the study .NOTE : .", "label": "", "metadata": {}, "score": "81.71338"}
{"text": "Will my privacy be protected ?Will I have time to think it over , perhaps discuss with my family , before deciding ?Can I back out later if I 'm not comfortable continuing with what is required ?", "label": "", "metadata": {}, "score": "82.069626"}
{"text": "IRB Administration .The IRB Administrator is responsible for coordinating the functions of the IRB and supervising IRB staff .This includes developing and maintaining systems relating to IRB submissions and records and assuring that the IRB Chair is provided staff support to fulfill the Chair 's responsibilities .", "label": "", "metadata": {}, "score": "82.3929"}
{"text": "The type of review required is determined by the level of risk participants are asked to assume when engaging in the research .See our Exempt & Expedited Reviews page for more information regarding exempt and expedited reviews .", "label": "", "metadata": {}, "score": "82.654236"}
{"text": "See the IRB SOP : Reliance Agreements for Multi - site Studies for more in - depth information .How does the reliance system work ?", "label": "", "metadata": {}, "score": "83.624374"}
{"text": "Attenuation may be achieved by gene deletions .or irreversible mutations in genes required for cell - to - cell . transmission or virulence .In order to be exempt from IBC review , in addition to using one of .", "label": "", "metadata": {}, "score": "83.83976"}
{"text": "Another issue is whether the safety profile of a product will .differ if the population has significantly different background . exposure to infectious diseases , as many of the vectors proposed to be . included in this exemption are viral vectors .", "label": "", "metadata": {}, "score": "83.96089"}
{"text": "No research participant shall be enrolled ( see definition of . enrollment in Section I - E-7 ) until the RAC review process has been . completed ( see Appendix M - I - B , RAC Review Requirements ) .", "label": "", "metadata": {}, "score": "83.97786"}
{"text": "Have taken an investigational drug in the last 6 months that may affect the normal process of blood cells .Any condition that in the view of the principal investigator ( PI ) would make the subject unsuitable for enrollment in this study .", "label": "", "metadata": {}, "score": "84.01677"}
{"text": "Using template IRB documents provided by the Network , each site was given responses to each question on the IRB application reducing the turnaround time for submission .", "label": "", "metadata": {}, "score": "84.19791"}
{"text": "Improvement initiatives have increased dramatically since the IOM report , \" To err is human : building a safer health system , \" was published [ 20 ] .", "label": "", "metadata": {}, "score": "84.35915"}
{"text": "What exactly will I be asked to do ?What is the risk , and how may I or others with my condition possibly benefit from the study ?", "label": "", "metadata": {}, "score": "84.87351"}
{"text": "Acknowledgment .This work is supported by a grant from the National Institute of Nursing Research ( 1RC2 NR011946 ; PI : Stevens KR ) .", "label": "", "metadata": {}, "score": "85.03992"}
{"text": "See also : The Institutional Review Board ( below ) .IRB Chair .The IRB Chair , appointed by the President upon the recommendation of the Vice President for Research Affairs , understands ethical issues and regulatory requirements related to human subject research .", "label": "", "metadata": {}, "score": "85.10602"}
{"text": "Investigator Training .To support its research community in the pursuit of the highest standards of research integrity and respect for human subjects , Loma Linda University maintains an education program to provide investigators with training in the ethical and regulatory requirements that govern human research .", "label": "", "metadata": {}, "score": "85.3027"}
{"text": "OHRP Posts FAQs on Informed Consent The Office for Human Research Protections ( OHRP ) has posted on its website a new set of Frequently Asked Questions ( FAQs ) on informed consent .", "label": "", "metadata": {}, "score": "85.56831"}
{"text": "characterized vectors , in the absence of any unexpected toxicities in .the initial study , subsequent biosafety assessments may not provide any .additional information .", "label": "", "metadata": {}, "score": "85.7519"}
{"text": "Appendix M - I - C-1 currently states : .Appendix M - I - C-1 : Initiation of the Clinical Investigation .No later than 20 working days after enrollment ( see definition . of enrollment in Section I - E-7 ) of the first research participant in .", "label": "", "metadata": {}, "score": "85.88661"}
{"text": "Your participation in clinical research is a valuable contribution to medical science .It is the essential road to discovery of new and better health care , and it is the way that doctors and researchers translate new knowledge into safe and effective practices and procedures in medicine and surgery .", "label": "", "metadata": {}, "score": "86.380554"}
{"text": "Background information may be obtained by contacting the NIH OBA by .email at oba@od.nih.gov .SUPPLEMENTARY INFORMATION : Human gene transfer is a maturing field .", "label": "", "metadata": {}, "score": "86.62538"}
{"text": "The signal was amplified , sampled at 200 Hz , and band - pass filtered between 0.3\u00ad70Hz ( Grass - Telefactor apparatus , West Warwick , RI ) .", "label": "", "metadata": {}, "score": "86.82237"}
{"text": "[ [ Page 27979 ] ] .( for example one would not expect significant differences between the .U.S. and Canada ) , but in order to make this criterion easily .", "label": "", "metadata": {}, "score": "87.13835"}
{"text": "An institution becomes \" engaged \" in human subjects research when its employees or agents ( all individuals performing institutionally designated activities or exercising institutionally delegated authority or responsibility ) .", "label": "", "metadata": {}, "score": "87.19281"}
{"text": "b. Possess biological properties that enable integration into .the genome ( e.g. , cis elements involved in integration ) ; or .c. Have the potential to replicate in a cell ; or .", "label": "", "metadata": {}, "score": "87.554214"}
{"text": "FOR FURTHER INFORMATION CONTACT :If you have questions , or require .additional information about these proposed changes , please contact the .NIH OBA by email at oba@od.nih.gov or telephone at 301 - 496 - 9838 .", "label": "", "metadata": {}, "score": "87.793365"}
{"text": "Purpose and Philosophy .Human subjects are a valuable resource that should not be utilized on meaningless investigations , even if participation carries no apparent risk .", "label": "", "metadata": {}, "score": "88.26008"}
{"text": "site , perhaps because the available population in which to study the .disease is limited .Given that there is no scientific rationale for .", "label": "", "metadata": {}, "score": "88.29898"}
{"text": "We tested three subjects who had been surgically implanted with bilateral depth electrode arrays into prefrontal cortex .Intracranial recordings can be ethically obtained in cases of medically intractable epilepsy , where they are used to precisely localize regions of seizure onset .", "label": "", "metadata": {}, "score": "88.47291"}
{"text": "The following are designated as affiliated components of Loma Linda University Adventist Health Sciences ( LLUAHSC ) for purposes of implementing Federal policy regarding human subject research : .", "label": "", "metadata": {}, "score": "88.99075"}
{"text": "Drive , Suite 750 , Bethesda , MD 20892 - 7985 .All written comments . received in response to this notice will be available for public . inspection in the NIH Office of Biotechnology Activities , 6705 .", "label": "", "metadata": {}, "score": "90.20316"}
{"text": "All three subjects had similar placements ( Supplementary Figure 1 ) .Intracranial recordings .We utilized the two most lateral electrode contacts on each array for a total of four electrodes per subject ( two per hemisphere ) and 12 electrodes across all three subjects .", "label": "", "metadata": {}, "score": "90.361755"}
{"text": "It 's also likely that the US military is interested in any artificial blood substitute , exsanguination being relatively problematic in war .BB IND 10719 Poly - SFH - P Injection [ Polymerized Human Hemoglobin ( Pyridoxylated ) , PolyHeme \u00ae . ]", "label": "", "metadata": {}, "score": "90.99162"}
{"text": "do integrate , given the safety record to date with AAV vectors and the .fact that they are more likely to remain episomal , including them in .", "label": "", "metadata": {}, "score": "91.13566"}
{"text": "2013 , Article ID 814360 , 7 pages , 2013 .View at Publisher \u00b7 View at Google Scholar .W. J. Burman , R. R. Reves , D. L. Cohn , and R. T. Schooley , \" Breaking the camel 's back : multicenter clinical trials and local institutional review boards , \" Annals of Internal Medicine , vol .", "label": "", "metadata": {}, "score": "91.482574"}
{"text": "RAC , that gene transfer products that employ plasmids or attenuated .Risk Group ( RG ) 2 viruses that are not designed to integrate into the .", "label": "", "metadata": {}, "score": "91.5645"}
{"text": "Benefit of research should outweigh its risk .Research must be conducted by qualified scientists .Scientists will do no harm , no death , no disabling injury .", "label": "", "metadata": {}, "score": "91.66857"}
{"text": "Working with Froedtert Health System .OCRICC recommends that you contact OCRICC no later than submission to the IRB .You can contact us by e - mail or visit our SCOUT site .", "label": "", "metadata": {}, "score": "91.714775"}
{"text": "Almost all viral vectors used in gene transfer are attenuated .compared to the wild - type virus .To be exempt from IBC review , there . must be data that the vector is attenuated compared to the wild type .", "label": "", "metadata": {}, "score": "91.79526"}
{"text": "at non - NIH - funded sites that do not have IBCs , for example clinics or .community hospitals that do not receive NIH funding for recombinant or . synthetic nucleic acid research .", "label": "", "metadata": {}, "score": "92.24583"}
{"text": "In drug development , it is recognized that children are not simply .small adults .Children 's immune systems are different and the . pharmacokinetics of viral vectors in pediatric patients may be altered ; . therefore , an initial safety study must be conducted in a pediatric .", "label": "", "metadata": {}, "score": "93.064354"}
{"text": "1995S-0158 Vol .44 Sup .Northfield Laboratories Inc.Public disclosure information re : institutional review boards , Penn State Milton S. Hershey Medical Center ( Hershey , PA ) and University of Cincinnati Medical Center ( Cleveland , OH ) .", "label": "", "metadata": {}, "score": "93.879715"}
{"text": "Lawrence A. Tabak , .Deputy Director , National Institutes of Health .[ FR Doc .2013 - 11222 Filed 5 - 10 - 13 ; 8:45 am ] .", "label": "", "metadata": {}, "score": "93.97705"}
{"text": "4 , pp .S21-S30 , 2000 .View at Google Scholar \u00b7 View at Scopus .K. R. Stevens , \" Small troubles , adaptive responses ( STAR-2 ) : frontline nurse engagement in quality improvement , \" in Proceedings of the Academy for Healthcare Improvement Conference : Advancing the Methods for Healthcare Quality Improvement Research , Arlington , Va , USA , 2012 .", "label": "", "metadata": {}, "score": "94.1423"}
{"text": "Do I need to make a submission if I 'm conducting Not Human Subject Research ?Non - Human Subject Research is defined as : .", "label": "", "metadata": {}, "score": "94.61181"}
{"text": "For these concerns , and many more , you have a strong advocate protecting your rights and interests : the Hospital for Special Surgery Institutional Review Board ( IRB ) .", "label": "", "metadata": {}, "score": "94.72667"}
{"text": "This definition includes community - based projects as well as clinical trials .Examples include : .MCW and Children 's Hospital .Froedtert Hospital and Marquette .", "label": "", "metadata": {}, "score": "95.227425"}
{"text": "Northfield is currently working with the US Army on developing the use of PolyHeme \u00ae on the battlefield , reflecting the potential utility of PolyHeme \u00ae for the military and the Department of Defense .", "label": "", "metadata": {}, "score": "95.29056"}
{"text": "152 - 157 , 2001 .View at Google Scholar \u00b7 View at Scopus .Institute of Medicine , To err Is Human : Building a Safer Health System , National Academies Press , Washington , DC , USA , 2000 .", "label": "", "metadata": {}, "score": "95.57567"}
{"text": "Respect for Persons .Acknowledge Autonomy .Protect those with diminished autonomy .Beneficence .Do no Harm .Maximize possible benefits and minimize possible harm .", "label": "", "metadata": {}, "score": "96.30174"}
{"text": "Research with vaccinia vectors was not .considered eligible for the exemption because of the adverse events .that were documented when vaccinia was used as a vaccine against .", "label": "", "metadata": {}, "score": "96.67441"}
{"text": "Human gene transfer is the deliberate transfer into human .research participants of either : .Recombinant nucleic acid molecules , or DNA or RNA derived .", "label": "", "metadata": {}, "score": "97.1728"}
{"text": "Dean or Department Head AND 2 ) .Risk Management : Jamie Schwister ( schwistj@uwosh.edu ) OR Raazia Riffat ( riffatr@uwosh.edu ) .The letter must be signed by the volunteer and then filed in the protocol record .", "label": "", "metadata": {}, "score": "97.61483"}
{"text": "Unanticipated adverse events ( either occurring internally or at an external site ) which meet the criteria above .Unanticipated adverse device effect .External Serious Adverse Events that meet the criteria above .", "label": "", "metadata": {}, "score": "97.65903"}
{"text": "Non - atopic donors will be recruited to donate blood , bone marrow , and/or buccal mucosa samples using conventional techniques .The investigational nature of the studies in which their blood , bone marrow and buccal mucosa samples will be used , as well as the risks and benefits of the donation process will be explained to all donors , and a signed informed consent document will be obtained .", "label": "", "metadata": {}, "score": "97.680115"}
{"text": "Proposed Actions Under the NIH Guidelines for Research Involving .Recombinant or Synthetic Nucleic Acid Molecules ( NIH Guidelines ) .SUMMARY : The NIH Office of Biotechnology Activities ( NIH OBA ) proposes . to revise the NIH Guidelines for Research Involving Recombinant or .", "label": "", "metadata": {}, "score": "97.86622"}
{"text": "Identifiable private information .Are you conducting research with decedents ?Research with decedents is not governed by the Office of Human Research Protection or the FDA .", "label": "", "metadata": {}, "score": "98.34311"}
{"text": "What is a Human subject ?A living individual about whom an investigator ( whether professional or student ) conducting research obtains .( 1 ) Data through intervention or interaction with the individual , or .", "label": "", "metadata": {}, "score": "98.75118"}
{"text": "Synthetic nucleic acid molecules , or DNA or RNA derived from . synthetic nucleic acid molecules , that meet any one of the following .criteria : .", "label": "", "metadata": {}, "score": "100.40947"}
{"text": "this exemption .The vectors OBA proposes to make eligible for this .exemption are derived from the following viruses : Adenoviruses , . serotypes 2 and 5 ; herpes simplex viruses 1 ( HSV-1 ) ; adeno - associated . viruses ( AAV ) ; and poxviruses , except for vaccinia .", "label": "", "metadata": {}, "score": "101.662415"}
{"text": "Help us advocate for meaningful protection of human subjects in research .Donating online with PayPal is quick and easy .Find out more on our Support page .", "label": "", "metadata": {}, "score": "102.075516"}
{"text": "The HSS Institutional Review Board .Edward C. Jones , MD , MA Assistant Attending Orthopaedic Surgeon , Hospital for Special Surgery Chairman , Institutional Review Board , Hospital for Special Surgery Assistant Professor of Orthopaedic Surgery , Weill Cornell Medical College .", "label": "", "metadata": {}, "score": "102.31955"}
{"text": "Breach of privacy or confidentiality including lost or stolen study records that contain private identifiable subject information .Any other problem that the investigator considers to be unanticipated and indicates that subjects or others are at increased risk of harm .", "label": "", "metadata": {}, "score": "102.51819"}
{"text": "Human subject means a living individual who is or becomes a participant in research , either as a recipient of the test article or as a control about whom an investigator ( whether professional or student ) conducting research obtains : .", "label": "", "metadata": {}, "score": "103.44136"}
{"text": "Human subject research activities conducted at MCW .Human subject research activities conducted or initiated by MCW employees or agents at any other site .Human subject research activities that make use of any MCW resources other than faculty or employee time commitment .", "label": "", "metadata": {}, "score": "105.07843"}
{"text": "Experiments Involving the Deliberate Transfer . of Recombinant or Synthetic Nucleic Acid Molecules , or DNA or RNA .Derived from Recombinant or Synthetic Nucleic Acid Molecules , into .", "label": "", "metadata": {}, "score": "105.682625"}
{"text": "40 , no . 1 , pp .279 - 290 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "107.84187"}
{"text": "You might want to think twice if you typically pass on the cranberries at Thanksgiving .While they may be a long way from zeroing in on the smoking gun , a University of Wisconsin Oshkosh student and faculty research collaboration is on the hunt for compounds with antiviral activity in cranberries , other Wisconsin fruits and juices and some more exotic varieties .", "label": "", "metadata": {}, "score": "109.043274"}
{"text": "--Adenovirus , serotypes 2 and 5 . --AAV , all serotypes .--Herpes Simplex virus 1 . --Pox Viruses , with the exception of vaccinia .", "label": "", "metadata": {}, "score": "121.6239"}
{"text": "Copyright \u00a9 2013 Darpan I. Patel et al .This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "134.30927"}
